1. Home
  2. PAR vs HRMY Comparison

PAR vs HRMY Comparison

Compare PAR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$12.81

Market Cap

887.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$26.70

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
HRMY
Founded
1968
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
887.7M
1.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
PAR
HRMY
Price
$12.81
$26.70
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$34.20
$46.70
AVG Volume (30 Days)
2.3M
644.8K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
2.71
Revenue
$455,547,000.00
$868,453,000.00
Revenue This Year
$9.82
$19.75
Revenue Next Year
$11.27
$12.88
P/E Ratio
N/A
$10.12
Revenue Growth
30.16
21.51
52 Week Low
$12.47
$25.52
52 Week High
$72.15
$40.87

Technical Indicators

Market Signals
Indicator
PAR
HRMY
Relative Strength Index (RSI) 26.11 30.74
Support Level $12.47 $25.71
Resistance Level $38.02 $28.99
Average True Range (ATR) 1.01 0.69
MACD 0.14 0.18
Stochastic Oscillator 8.94 0.43

Price Performance

Historical Comparison
PAR
HRMY

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: